Stay updated on PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib
Sign up to get notified when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.

Latest updates to the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page
- Check3 days agoChange DetectedThe MedlinePlus related topics section no longer displays the 'Ovarian cancer' and 'MedlinePlus Genetics' links on the PAOLA-1 study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoChange DetectedScreenshots indicate only minor UI/layout adjustments on the study details page; essential content such as trial design, eligibility criteria, and outcomes appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check46 days agoChange DetectedPage updated to v3.1.0, removing several drug-safety topic areas and deprecating them; overall content breadth contracts rather than expanding, with no visible changes to core content or time-sensitive details.SummaryDifference0.4%

- Check60 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.1%

- Check67 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib
Enter your email address, and we'll notify you when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.